CNS Pharmaceuticals CNSP 深 沪
等待开盘 05-19 09:30:00 美东时间
4.71
-0.240
-4.85%
华盛通- 最 高5.005
- 今 开5.00
- 成交量 4.02万股
- 最 低 4.61
- 昨 收 4.95
- 总市值 688.34万
- 52周最高 13.7988
- 市盈率 静 --
- 换手率 2.75%
- 52周最低 1.90
- 委 比 79.90%
- 总股本 146.14万
- 历史最高 5121000.00
- 量 比 0.38
- 振 幅 7.98%
- 历史最低 1.90
- 每 手 1
- 风险率 3.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(7.30) per share which missed the analyst consensus estimate of $(5.37) by 35.94 percent. This is a 61.44 percent increase over losses of $(18.93) per share
05-14 20:28
CNS Pharmaceuticals Q1 net loss widens to $4.94 million from year-ago quarter
CNS Pharmaceuticals Q1 net loss widens to $4.94 million from year-ago quarter CNS Pharmaceuticals posted a net loss of $4.94 million for the quarter ended March 31, 2026, widening from $4.3 million a year earlier. Research and development expense rose to $3.54 million from $3.24 million, on higher p
05-14 19:56
What's Going On With CNS Pharmaceuticals Stock On Wednesday?
CNS Pharmaceuticals plans a pivot to an acquisition-led strategy, capital raise, and technicals signal momentum with caution.
05-06 21:51
3 Penny Stocks to Watch Now, 5/5/26
CNS Pharmaceuticals ($CNSP), Elong Power Holding ($ELPW), and Skycorp Solar Gro...
05-06 00:22
Gold Falls Over 2%; US Factory Orders Rise In March
US stocks traded lower with Dow down 0.4%. NASDAQ up 0.07% while S&P 500 fell 0.03%. Norwegian Cruise Line beat Q1 estimates but cut FY2026 guidance.
05-05 00:05
Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?
CNS Pharmaceuticals stock underwent a massive rally alongside a $22.5 million p...
05-04 21:58
Dow Falls Over 150 Points; Tyson Foods Posts Upbeat Earnings
US stocks fell, Dow dropped 150 points. Dow at 49,321.96, NASDAQ at 25,109.76, S&P 500 at 7,223.30. Tyson Foods beat earnings, stock up. Energy and Xanadu Quantum down.
05-04 21:40
CNS Pharmaceuticals Enters Securities Purchase Agreements For ~$22.5M Private Placement Of 650,000 Shares At $2.30 Per Share And Warrants To Purchase Up To ~9.1M Shares At Purchase Price $2.299 Per Warrant
The private placement includes participation from institutional healthcare investors, including ADAR1 Capital, Ikarian Capital, Stonepine Capital Management and Nazare Partners.Pursuant to the terms of the securities
05-04 19:13
Market-Moving News for May 4th
EBAY: 13% | GameStop's Cohen Threatens Proxy War In High-Stakes eBay Bid CNSP: 165% | CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing ORGN: -46% | Origin
05-04 19:12
CNS Pharmaceuticals Launches Global Search For Neurology And Oncology Assets, Shifts Focus From Glioblastoma
Newly formed executive team initiates global search for differentiated therapeutic assets for neurology and oncology indications, two of biopharma's largest and fastest-growing marketsStrategic transformation driven by a
03-11 20:42
